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SUMMARY 
Monocytes are circulating, short-lived mononuclear phagocytes, which in mice and 
man comprise two main subpopulations. Murine Ly6C+ monocytes display 
developmental plasticity and are recruited to complement tissue-resident 
macrophages and dendritic cells on demand. Murine vascular Ly6C- monocytes 
patrol the endothelium, act as scavengers and support vessel wall repair. Here we 
characterized population and single cell transcriptomes, as well as enhancer and 
promoter landscapes of the murine monocyte compartment. Single cell RNA-seq and 
transplantation experiments confirmed homeostatic default differentiation of Ly6C+ 
into Ly6C- monocytes. The main two subsets were homogenous, but linked by a 
more heterogeneous differentiation intermediate. We show that intravascular 
monocyte differentiation occurred through de novo enhancer establishment and 
activation of pre-established (poised) enhancers. Generation of Ly6C- monocytes 
involved induction of the transcription factor C/EBPβ and C/EBPβ-deficient mice 
lacked Ly6C- monocytes. Mechanistically, C/EBPβ bound the Nr4a1 promoter and 
controlled expression of this established monocyte survival factor.  
 
147 words 
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INTRODUCTION 
Monocytes are circulating, short-lived cells that are, together with tissue resident 
macrophages and dendritic cells (DC), classified as mononuclear phagocytes 
(Ginhoux and Jung, 2014). Adult steady state monopoiesis occurs in bone marrow 
(BM), where monocytes arise in a developmental sequence from dedicated precursor 
cells. Specifically, monocyte-macrophage DC progenitors (MDP) (Fogg et al., 2006) 
give rise to common monocyte progenitors (cMoP) committed to monocyte 
generation (Hettinger et al., 2013). Two main CD14+CD16- and CD14int CD16+ 
monocyte populations have been identified in human blood (Passlick et al., 1989). 
Corresponding subsets in mice are defined as CX3CR1int CCR2+ CD62L+ CD43low 
Ly6Chi  (Ly6C+) and CX3CR1hi CCR2- CD62L- CD43hi Ly6Clo (Ly6C-) cells (Geissmann 
et al., 2003; Palframan et al., 2001; Sunderkötter et al., 2004).  
 Ly6C+ monocytes arise in the BM, where they represent the majority of 
monocytes (~90%). Once in the blood, Ly6C+ monocytes are characterized by a high 
degree of developmental plasticity. Specifically, these cells sense injury and 
extravasate into tissues, where their descendants have emerged as a highly plastic 
cellular system that complements the classical tissue-resident mononuclear 
phagocyte populations, i.e. macrophages and DC (Mildner et al., 2013). Also during 
homeostasis, Ly6C+ monocytes contribute to macrophage compartments of selected 
tissues (Varol et al., 2007; Molawi et al., 2014; Bain et al., 2016; Kim et al., 2016). 
The latter is likely related to environmental or physiological challenges of these 
organs and can vary among genders and mouse strains. Ly6C- monocytes are 
considered to remain in the vasculature. A fraction of these cells patrols the vessel 
walls, acting as scavengers and orchestrating tissue repair (Auffray et al., 2007; 
Carlin et al., 2013).  
 Circulating Ly6C+ monocytes give rise to Ly6C- monocytes, as shown for mice 
and primates by sequential BrdU incorporation of the subset (Sugimoto et al., 2015; 
Yona et al., 2013), re-population kinetics following depletion regimes (Sunderkötter et 
al., 2004), and direct adoptive transfer of Ly6C+ monocytes (Varol et al., 2007; Yona 
et al., 2013). Furthermore, following monocyte precursor engraftment, Ly6C- cells 
arise with delay compared to Ly6C+ monocytes (Varol et al., 2007; Hettinger et al., 
2013).  
Development of both blood monocyte subsets depends on the 'pioneer' or lineage 
determining transcription factor PU.1 (encoded by Spi1; Scott et al., 1994). Mutations 
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of Ccr2 (Serbina and Pamer, 2006), Irf8 (Kurotaki et al., 2013) and Klf4 (Alder et al., 
2008; Feinberg et al., 2007) preferentially affect Ly6C+ monocytes, while Nr4a1 
(Nur77) deficiency affects Ly6C- monocytes (Hanna et al., 2011). However, fate 
mapping experiments have shown that absence of Ly6C+ monocytes can trigger a 
compensatory half-life extension of Ly6C- cells, and thereby mask the impairment of 
the Ly6C- compartment in mutants (Yona et al., 2013). Thus, deficiencies, including 
Irf8, Klf4 and CCR2, generally affect both monocyte subsets (Alder et al., 2008; 
Kurotaki et al., 2013; Yona et al., 2013). Likewise, also Nr4a1-deficient Ly6C+ 
monocytes fail to compete with their wild type counterpart in mixed BM chimeric mice 
(Hanna et al., 2011).  
 Here we have systematically characterized the murine circulating monocyte 
subsets, including population-level and massively parallel single cell RNA 
sequencing (MARS-seq (Jaitin et al., 2014)), a global analysis of accessible 
chromatin regions (ATAC-Seq) and indexed chromatin immuno-precipitation (iChIP) 
to define epigenetic landscapes. We show that steady state differentiation of Ly6C+ 
monocytes into Ly6C- cells ensued rapid transcriptomic changes accompanied by 
prevalent de novo gain of enhancer activity with only minor promoter changes. 
Including data from grafted Ly6C+ monocytes, our results support and extend 
previous reports showing developmental progression from Ly6C+ monocytes to Ly6C- 
cells. Mechanistically, we identified the induction of CCAAT-enhancer-binding protein 
beta (C/EBPβ) as part of the Ly6C- differentiation program, activating the monocyte 
survival factor Nr4a1, and show that C/EBPβ-deficiency impaired the generation of 
circulating Ly6C- monocytes. 
 
RESULTS 
Molecular characterization of murine monocytes and their progenitors. To map 
molecular determinants guiding monocyte development (Fig. 1A), we isolated MDP, 
cMoP, BM Ly6C+ and Ly6C- monocytes, as well as the three phenotypically distinct 
Ly6C+, Ly6Cint and Ly6C- blood monocyte populations from adult C57BL/6 mice (Fig. 
1B) and performed a transcriptome analysis.  
 Comparative analysis of the populations revealed disparate regulation of 6064 
genes (> two-fold differences in any pairwise comparison among a total of 15733 
genes; Fig. 1C, D and Fig. S1A). A cluster defined by MDP (cluster I) was 
characterized by genes associated with a progenitor phenotype, including Hoxa7, 
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Cd34 and Flt3 (Fig. 1C, D). Cluster II comprised genes co-expressed by MDP and 
cMoP, including Kit, S1pr3, Myc and Myb (Fig. 1C, D). Genes, such as Cdk2, Cdk4 
and members of the Mcm gene family indicated overrepresentation of the cell cycle 
pathway (p = 3.5e-18, Fig. S1B). An even stronger enrichment of cell cycle genes was 
found in cluster III (p = 1.6e-57, Fig. S1B) defined by high expression in cMoP and 
BM Ly6C+ monocytes, indicating that at least a fraction of BM Ly6C+ monocytes 
retained proliferative capacity, as reported earlier (Hettinger et al., 2013). Also 
classical Ly6C+ monocyte genes like Ly6c2 and Sell (CD62L) belonged to this cluster. 
Genes shared by Ly6C+ monocytes in BM and blood were represented in cluster IV 
(694 genes), enriched for genes involved in response to viruses (p = 2.7e-5, Fig. 
S1B) and comprising Ccr2, Mmp8 and Lgals3, as well as the transcription factors 
Cebpa, Fos and Cebpd (Fig. 1D, Fig. S1B). Genes that showed a gradual increase 
of expression from Ly6C+ to Ly6C- monocytes (including BM Ly6C- cells), formed 
cluster V, comprising Cebpb, Klf2 and Itgal and genes involved in inflammatory 
pathways (Fig. S1B). Cluster VI included genes strongly up-regulated from Ly6C+ to 
Ly6C- monocytes, such as Pparg, Itgax (CD11c) and Nr4a1. Therefore, Cebpb 
transcripts were already detectable in Ly6C+ BM monocytes, whereas Nr4a1 
expression was induced in Ly6C+ blood monocytes and increased in Ly6C- cells (Fig. 
1D). Notably and supporting the notion that Ly6C- monocytes represent intra-
vascular macrophages (Ginhoux and Jung, 2014), cluster VI also comprised genes 
characteristic of tissue resident macrophages, such as Apoe and Cd36.  
 Murine blood harbours, in addition to Ly6C+ and Ly6C- populations, monocytes 
that display intermediate Ly6C and were interpreted as monocyte differentiation 
intermediates. The population-based analysis did not reveal a specific gene module 
unique to Ly6Cint monocytes; rather, these cells displayed an intermediate profile, 
sharing signatures with both Ly6C+ and Ly6C- monocytes (Fig. 1D). Similar results 
were obtained with an independent data set, even though some differences between 
the experiments were evident, indicating the sensitivity of monocytes towards small 
environmental differences (Fig. S2).  
 
Transferred BM Ly6C+ monocytes adopt a transcriptional profile comparable to 
Ly6C- monocytes. The substantial expression changes between Ly6C+ and Ly6C- 
monocytes suggested that linear progression of these cells (Sunderkötter et al., 
2004; Varol et al., 2007; Yona et al., 2013) was driven by transcriptomic changes. 
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Transferred Ly6C+ monocytes isolated from BM or spleen lose Ly6C expression and 
gain CX3CR1, rendering them phenotypically indistinguishable from Ly6C- monocytes 
(Varol et al., 2007; Yona et al., 2013); however the molecular relationship of grafted 
monocytes and their derivatives to host monocyte populations had not been 
investigated. 
To probe whether converted monocytes reflected the molecular changes seen 
in endogenous Ly6C- monocytes, we isolated CD117- CD11b+ CD115+ Ly6C+ BM 
monocytes from CD45.1 congenic mice and transferred them into the bloodstream of 
CD45.2 WT animals (Fig. 2A). Cells were retrieved from recipient blood 24h, 36h 
and 48h after transfer, sorted based on their CD45.1, CD11b and CD115 expression 
and subjected to comprehensive transcriptional analysis (n=2 per time point, Fig. 2B). 
During this time, transferred monocytes gradually lost the Ly6C surface marker (Fig. 
2B). Host Ly6C+, Ly6Cint and Ly6C- blood monocyte populations were isolated 
alongside to control for potential injection-related side effects. In parallel, graft-
derived cells were also retrieved from recipient spleens (Fig. S3). 
 Transcriptional profiling of monocyte samples revealed many genes to be 
differentially regulated in any pairwise comparison (1677 genes, Fig. 2C, Fig. S4A). 
We identified a cluster of genes specific for the Ly6C+ BM monocyte graft (cluster I) 
(Fig. 2C, D). Importantly, genes of the 'Ly6C+ monocyte gene signature' (including 
Ccr2, Lyz2, Sell and Irf4) were all down-regulated upon transfer, independently of the 
time point of retrieval (cluster II, III). Of note, Ly6C protein abundance persisted 
despite Ly6c2 mRNA reduction in transferred cells 24h after transfer (Fig. 2B,D). 
Cluster V and VI on the other hand, comprised genes gradually up-regulated in 
transferred cells and shared with host Ly6C- monocytes. This included members of 
the 'Ly6C- gene signature', such as Cx3cr1, Itgax, Bcl2, Pparg, Cd36, as well as 
Cebpb and Nr4a1. Also genes associated with MHCII expression, such as Cd74, H2-
ab1 and H2-eb1 were part of this cluster and higher expressed in cells re-isolated 
24h after transfer compared to other time points. Cd209a was however absent from 
transferred cells (Fig. 2D). Genes highly expressed in Ly6C- host monocytes, but 
less prominent in grafted cells retrieved at 48h, grouped in cluster VII. Clusters IV 
and VIII comprised genes up-regulated shortly after monocyte transfer, which may be 
related to the ex vivo manipulation of the monocytes and transfer-associated stress.  
 To evaluate the relationship between grafted monocytes and their host 
counterparts, we compared expression of the 48h time point (without BM-specific 
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genes; cluster II-VIII) to the transcriptomes of host Ly6C+, Ly6Cint and Ly6C- cells, 
respectively (Fig. 2E). Global correlation of gene expression of the transferred cells 
versus Ly6C+ host cells was only moderate (r =0.51), while the correlation to Ly6Cint 
(r = 0.81) and Ly6C- (r = 0.85) host monocytes was higher (Fig. 2E), demonstrating 
their conversion. In contrast, the earlier 24h time point showed a higher correlation 
towards the Ly6Cint than Ly6C- monocyte phenotype (r = 0.79 vs. r = 0.69; Fig. S4B) 
 Collectively, our data demonstrate that as a population, 24h after transfer 
grafted Ly6C+ monocytes in blood and spleen adopt a molecular signature that 
overlaps with Ly6Cint host cells and shifts 48h after transfer towards a Ly6C- 
monocyte profile. 
 
Single cell RNA-Seq analysis reveals homogeneity of Ly6C+ and Ly6C-, but 
heterogeneity of Ly6Cint blood monocytes. 
The transcriptional profiles described above were obtained from populations of sorted 
cells according to a limited number of canonical markers and bulk gene expression 
signatures may represent heterogeneous subsets with various dynamics (Paul et al., 
2015). Although engrafted Ly6C+ monocytes can acquire a phenotype and 
expression signature similar to Ly6C- host monocytes, remaining differences could 
indicate that Ly6C- monocytes represent a heterogeneous population of potentially 
distinct origins. To test this possibility, we performed MARS-seq (Jaitin et al., 2014; 
Paul et al., 2015) of Lin- CD11b+ CD115+ monocytes (1,098 cells) isolated from blood 
of adult C57BL/6 mice. For better resolution of intermediate monocytes we 
complemented this analysis with additional 365 Lin- CD11b+ CD115+ Ly6Cint 
monocytes (Fig. S5A-C). 
 Using indexed flow cytometry sorting followed by MARS-seq, we could relate 
expression profiles of individual cells to respective mean fluorescence intensities 
(MFI) of Ly6C and CD62L. De novo clustering analysis separated cells into 4 
transcriptionally distinct subgroups, corresponding to Ly6C+ and Ly6C- groups and 
two intermediate states (Fig. 3A, Suppl. Tab. 1). Expression analysis identified 477 
differentially expressed genes (q < 1e-3, chi-square test), revealing heterogeneity 
within Ly6Cint monocytes. Cluster I corresponded to 224 cells with high Ly6C and 
CD62L MFI (Fig. 3B). Cluster II (148 cells) and cluster III (271 cells) comprised 
monocytes with intermediate surface Ly6C and CD62L expression. Cluster IV (820 
cells) included cells with low Ly6C and low CD62L MFI. In line, the Lin- CD11b+ 
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CD115+ Ly6Cint monocyte subset was enriched for cells from clusters II and III (Fig 
S5C). 
Focussing on gene expression, we could relate the gene program of Ly6C+ 
monocytes (including Lyz1-2, Ccr2, Ly6c2, Mpeg1, Sell and Irf8) to cluster I cells (Fig. 
3C, Fig. S5D). Monocytes within cluster II, characterized by intermediate surface 
display of Ly6C and CD62L, showed specific expression of MHCII-related genes 
(Cd74, H2-aa, Ciita) and expressed Ccr2, as well as Cd209a (Fig. S5E). While our 
data closely link these cells to the Ly6Cint subset, they might be related to a recently 
reported monocyte subset biased to generate DC-like cells (Menezes et al., 2016). 
Surface MHCII expression by 50% of the Ly6Cint monocytes was further validated by 
flow cytometry analysis (Fig. S5F). Cluster III monocytes did not display a specific 
expression signature, but showed intermediate expression of Cebpb, Nr4a1, Ccr2, as 
well as MHCII-related genes. The 'Ly6C- gene program', which included Nr4a1, 
Cebpb, Cd36, Pparg, Itgax and Itgal, was most evident in cluster IV monocytes (Fig. 
3C).  
 To illustrate developmental relationship between the monocytes, we next used 
diffusion maps to project each single cell to a location in two-dimensional space 
(Haghverdi et al., 2015). All four clusters were separated territorially in the projected 
map (Fig. 3D-E). To further visualize expression patterns across the single cell data, 
we overlaid gene expression on the dimensionality reduction space. Sell and Ly6c2 
were found restricted to Ly6C+ monocytes in cluster I, while Lyz2 and Ccr2 
expression was also shared by cluster II cells (Fig. 3F). Cluster II also specifically 
expressed Cd209a, MHCII-related genes, such as H2-aa, while Cd36 was absent. 
Cluster III represented an intermediate subset that linked cluster I with cluster IV, i.e. 
Ly6C+ and Ly6C- monocytes, characterized by induction of Itgal, Cebpb and Cd36 
expression. Expression of these genes peaked in cluster IV, and was accompanied 
by Nr4a1 expression (Fig. 3F). 
 To investigate whether cluster II and III monocytes represent ontogenetically 
separate populations or related developmental stages, we analysed MARS-seq data 
of Lin- CD11b+ CD115+ blood monocytes derived from Cx3cr1cre:R26-YFP animals. 
Due to the time-dependent probability of Cre-mediated genome editing of the R26-
YFP locus of each individual cell, only few Ly6C+ monocytes express YFP in these 
mice, while all Ly6C- monocytes are YFP+ (Yona et al., 2013). YFP expression can 
hence serve as a temporal indication of monocyte lifespan. Projecting these newly 
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sorted cells on our clusters (Fig. 3A, Figs. S5G-H), we identified the four clusters in 
Cx3cr1cre:R26-YFP monocytes and related them to their YFP expression. In line, only 
5,7% of the Ly6C+ monocytes expressed YFP, whereas almost all (93,7%) of the 
Ly6C- were YFP positive (Fig. 3G). In contrast, half of the cells in clusters II and III 
expressed YFP (44,4% and 42,9% respectively), indicating that both stages are 
intermediate to the short-lived Ly6C+ cells and the longer-lived Ly6C- monocytes. 
 Collectively, single cell RNA-Seq analysis established that Ly6C+ and Ly6C- 
monocytes represent in steady state homogeneous populations, but reveal a certain 
degree of heterogeneity in the Ly6Cint monocyte compartment.  
 
Chromatin analysis reveals gain of enhancer activity in Ly6C- monocytes with 
only minor promoter changes. Steady state conversion of short-lived Ly6C+ into 
Ly6C- blood monocytes provides a unique model to study contributions of epigenetic 
changes in a rapid, physiologically relevant differentiation process. To investigate the 
epigenetic landscapes of murine Ly6C+, Ly6Cint and Ly6C- blood monocytes, we 
profiled four histone modifications by indexing-first chromatin IP (iChiP) (H3K4me1, 
H3K4me2, H3K4me3, and H3K27ac; (Lara-Astiaso et al., 2014)) and performed an 
chromatin accessibility assay (transposase-accessible chromatin; ATAC-seq) 
(Buenrostro et al., 2013). 
 Histone modifications inform on the activity state of cis-acting genomic 
regulatory elements. Specifically, promoters are identified according to proximity to 
transcription start sites (TSS) and tri-methylation of lysine 4 on the histone H3 N-
terminal tail (H3K4me3), while enhancers are defined by their distance from the TSS 
(>1kb) and enrichment of H3K4me1 and H3K4me2 marks (Heintzman et al., 2007). 
Enhancers can be further classified into 'poised' (H3K4me1+) and active (H3K4me1+, 
H3K27ac+) (Creyghton et al., 2010).  
 Analysis of total H3K4me3 peaks (peak center <1kb from TSS) in the main 
monocyte subsets identified 9,635 promoters, 35 of which were differently used 
between Ly6C+ and Ly6C- monocytes (Fig. 4A). This represents 0.36% differentially 
regulated H3K4me3 marks, whereas transcriptonal changes among the monocytes 
reached 8.4% (Fig. 4B). Of the altered H3K4me3-characterized promoters, seven 
showed loss during Ly6C+ to Ly6C- differentiation, including Sell, Clec5 and Ly6c2 
(Fig. 4A,C). 19 promoters were established de novo in Ly6C- monocytes, including 
Bcl2a1b, Pparg, Cd36 and Il1b, while 8 promoters displayed an increased H3K4me3 
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signal in Ly6C- monocytes (Fig. 4A,C; Suppl. Tab. 2). 
Analysis of distal H3K4me2 marks in the monocyte populations identified a 
total of 19,975 enhancers, 654 (3.3%) of which presented dynamic behavior. During 
the Ly6C+ to Ly6C- differentiation, 35 enhancers lost marks (28 genes, 
e.g. Ly6c2, Ccr1) and 120 enhancers decreased their H3K4me2 signal (94 genes, 
e.g. Ccr2, Sell) this included one of the Nr4a1 enhancers (Fig. 4C). Differentiation of 
Ly6C+ to Ly6C- monocytes involved de novo mark acquisition of 181 enhancers, 
located in the vicinity of 129 genes, such as Bcl2a1b, Klf4, Cd300e and Pparg; 
additionally, 318 enhancers (211 genes, e.g. Mir146, Sell, Nr4a1, Cd36) increased 
their H3K4me2 signal during the Ly6C+ to Ly6C- monocyte conversion (Fig. 4A,C; 
Suppl. Tab. 2). To confirm these results we characterized the distal 
H3K4me1+ signal during the Ly6C+ to Ly6C- conversion. H3K4me1 signal dynamics 
in enhancers followed a pattern similar to H3K4me2 (Fig. 4A and Fig. S6B), 
corroborating that Ly6C+ to Ly6C- monocyte conversion involves de novo enhancer 
generation, rather than enhancer decommission, i.e. me1 and me2 de-methylation.  
Finally, prominent changes were evident in histone acetylation, with 77 regions 
(60 genes) displaying reduced H3K27ac modification and 563 regions (313 genes) 
gaining acetylation during monocyte differentiation. This was consistent with the high 
number of de novo enhancers generated during the conversion.  
Importantly, Ly6Cint monocytes were characterized by an overlapping 
phenotype and shared histone modification patterns with Ly6C+ as well as Ly6C- 
monocytes, but lacked unique regulatory elements (Fig. 4D). Collectively, this 
revealed a specific and prevalent gain of enhancer activity in Ly6C- monocytes with 
only minor H3K4me3-marked promoter changes. 
To define open chromatin regions and identify transcription factor binding 
motifs enriched for the specific monocyte populations, we applied ATAC-seq 
(Buenrostro et al., 2013) to circulating Ly6C+, Ly6Cint and Ly6C- cells. Correlated 
replicates (Fig. S6A) allowed detection of 40,572 total accessible regions in all 
monocytes populations. Classical monocyte genes, such as Cx3cr1, Nr4a1 and Itgax, 
showed an highly overlapping open chromatin pattern in all 3 populations, even 
though small subset-specific peak changes were evident - for instance in the Nr4a1 
and Itgax loci (Fig. S6C). Global quantification of differential ATAC peaks between 
Ly6C+ and Ly6C- monocytes revealed 423 peaks (corresponding to 350 genes) that 
displayed a >2 fold enrichment in Ly6C+ monocytes and 866 peaks (corresponding to 
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692 genes) that were increased in Ly6C- monocytes (Fig. 4E).  
 To identify potential transcription factors responsible for transcriptome and 
epigenome regulation during monocyte conversion, we examined the ATAC data for 
enrichment for transcription factor binding motifs within the differential accessible 
regions (Lara-Astiaso et al., 2014; Lavin et al., 2014). We identified both known and 
previously unknown candidate regulators, including Spi1 (Pu.1), Fosl2, Cebp and 
SpiC motifs enriched in Ly6C+ monocytes and Nr4a1, Spi1, Cebp, Runx2 and Klf 
motifs enriched in Ly6C- monocytes (Fig. 4F). 
 We next compared the predicted motif enrichment in monocyte subsets with 
the transcription factor expression in these cells (Fig. 4G, Fig. S6D). Spi1, Klf2, Klf4 
and Nr4a1 were prominently expressed in monocytes and increased with acquisition 
of the Ly6C- phenotype, confirming the requirement of these transcription factors for 
monocyte differentiation (Feinberg et al., 2007; Hanna et al., 2011; Scott et al., 1994). 
Notably, RNA-Seq analysis further revealed distinction within certain transcription 
factor families, such as the one comprising various members of the C/EBP family, 
which bind similar motifs and are therefore not resolved by chromatin footprint 
analysis. Within the C/EBP family, Cebpb was the most prominently expressed gene, 
correlating well with the predicted transcription factor motif analysis. Generally, 
monocyte conversion was associated with a shift from C/EBPα and δ to 
C/EBPβprevalence (Fig. 4G).   
 
Ly6C- monocytes are dependent on the transcription factor C/EBPE.  
Monocyte conversion was associated with prominent alterations within the C/EBP 
transcription factor family (Fig. 4G). Specifically, up-regulation of Cebpb in Ly6C- 
monocytes compared to Ly6C+ cells, as well as after monocyte transfer suggested a 
role of C/EBPβ in late monocyte development (Fig. 1C and Fig. 2D). Indeed, 
monocytes were reported to be affected in C/EBPβ-deficient animals (Tamura et al., 
2015), although it had not been addressed whether the effect was cell-intrinsic or 
restricted to a specific subset. 
 Analysis of peripheral blood of C/EBPβ-deficient mice and littermate controls 
revealed that Ly6C+ monocytes were present in comparable frequency in both mouse 
strains, Ly6Cint monocytes showed a 50% reduction but Ly6C- blood monocytes were 
absent (Fig. 5A). Also BM Ly6C- monocytes were strongly reduced, while monocytic 
precursors, such as MDP, cMOP or BM Ly6C+ monocytes were present at similar 
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frequencies in mutants and controls (Fig. 5B). To investigate, if the monocyte 
impairment of Cebpb-/- mice resulted from a cell-intrinsic defect, we performed a 
competitive repopulation assay, in which Cebpb-/- BM was mixed 1:1 with WT 
littermate BM and transplanted into lethally irradiated WT recipients. Analysis of the 
resulting chimeras 8 weeks after engraftment revealed that both genotypes 
contributed equally to MDP and cMoP (Fig. 5C). C/EBPβ-deficient BM cells had a 
disadvantage in generating Ly6C+ and Ly6Cint monocytes in BM and blood. Moreover, 
Ly6C- monocytes were almost entirely derived from WT BM cells with hardly any 
C/EBPβ-deficient Ly6C- monocytes detectable (ratio 95 +/- 33; Fig. 5C). These data 
establish the direct cell-intrinsic requirement of C/EBPβ for the generation or survival 
of Ly6C- monocytes.  
 Encoded by an intron-less gene, C/EBPβ is expressed in distinct isoforms with 
different biological functions (Smink et al., 2009). A short, N-terminally truncated 
protein, the liver-enriched transcriptional inhibitory protein (LIP), lacks the 
transactivation domain and acts mainly as a dominant-negative C/EBPβ isoform 
(Descombes and Schibler, 1991). As compared to a C/EBPβ WT control (CoKi; 
C/EBPβ cDNA inserted into the cebpb locus) (Wethmar et al., 2010), expression of 
the C/EBPβ LIP isoform (Bégay et al., 2015) failed to rescue the developmental 
defect of Ly6C- monocytes observed in Cebpb-/- mice (Fig. 5D). Moreover, LIP 
animals displayed a strong reduction in all monocyte subsets (Fig. 5D). The 
dominant effect of this physiological C/EBP inhibitor corroborates the importance of 
C/EBP transcription factor for monocyte differentiation and the requirement for proper 
C/EBP isoform balance.  
 To further dissect the impairment of the Ly6C- monocyte compartment by the 
C/EBPβ deficiency, we isolated monocytes of Cebpb-/- mice and control littermates 
and performed RNA-Seq on these samples (Fig. 5E). Clustering of differentially 
expressed genes revealed that the 'Ly6C- monocyte gene signature' was down-
regulated in C/EBPβ-deficient Ly6Cint cells indicating a developmental block of the 
'Ly6C- gene program' (Fig. 5E). Respective gene clusters (I, II) included Cebpb, 
Nr4a1, Bcl2 and Itgal (Fig. 5F). The 'monocytic Ly6C+ gene signature' including 
Ly6c2, Lyz2, Sell and Fos, was present in C/EBPβ-deficient Ly6C+ monocytes 
(cluster III, IV) (Fig. 5F). We also identified genes specifically up-regulated in Ly6C+ 
and Ly6Cint Cebpb-/- monocytes compared to controls (cluster V, VI). These clusters 
comprised other members of the C/EBP family, such as Cebpa and Cebpe, 
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suggesting compensation for or loss of repression by C/EBPβAlso genes belonging 
to the 'MHC gene family', such as H2-aa, H2-eb1 and Cd74, were higher expressed 
in C/EBPβ-deficient Ly6Cint monocytes (cluster VI, Fig. 5F). Similarly, Cd209a was 
strongly enriched in these cells, while Cd36 was absent, indicating that the 
alternative differentiation pathway of Ly6C+ monocytes towards Cd209a-expressing 
Ly6Cint cells is probably C/EBPβ-independent.  
 
C/EBPβinteracts with the Nr4a1 promoter and induces its expression.  
Impaired development of Ly6C- monocytes in Cebpb-/- mice and the profound 
competitive disadvantage of mutant cells over C/EBPβ-proficient monocytes (Fig. 5A, 
C) phenocopied Nr4a1-deficient animals (Hanna et al., 2011). Nr4a1 gene 
expression was strongly decreased in Ly6Cint Cebpb-/- monocytes (to 30 %; Fig. 5F), 
suggesting that C/EBPβ is involved in Nr4a1 regulation.  
 To identify C/EBPβ binding sites at the Nr4a1 locus, we examined the 
C/EBPβbinding pattern of cultured monocyte-derived cells (Bornstein et al., 2014). 
Two open chromatin regions upstream of the first exon of the Nr4a1 gene were found 
in all monocyte subsets (-50bp (blue symbol) and -850bp (purple symbol) from the 
TSS). Sequence analysis revealed that all regions harboured C/EBPβ binding motifs 
(Fig. 6A). In these cells, the -850bp site was occupied by C/EBPβ, whereas the -
50bp site displayed only a weak signal (Fig. 6A). Notably, this imperfect site had 
been reported earlier to be involved in C/EBPβ-dependent Nr4a1 expression in rat 
cells (El-Asmar et al., 2009). In addition, a -4kb distal enhancer element was 
occupied by C/EBPβ(white symbol; Fig. 6A). To probe for differential contributions of 
the elements, we cloned combinations of regulatory regions upstream to a firefly 
luciferase gene reporter and transfected Cebpb-/- MEF cells with the constructs (Fig. 
6B). Following introduction of ectopic C/EBPβ, we measured relative luciferase 
expression normalized to renilla luciferase activity. C/EBPβ addition did not induce 
luciferase expression in Cebpb-/- MEF cells transfected with control, the -50bp region 
or the -4kb enhancer plasmids (Fig. 6B). In contrast, constructs that contained the -
850kb site showed a C/EBPβ-dependent increase in luciferase activity. Of note, the -
4kb enhancer element in combination with the -850bp site further increased 
expression, but also affected the background signal in the absence of exogenous 
C/EBPβ, indicating C/EBPβ-dependent and independent interaction of these two 
regulatory elements. Collectively, our data suggest a critical role of C/EBPβ in the 
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regulation of Nr4a1 expression during monocyte conversion.  
 
DISCUSSION 
Monocytes and their descendants have emerged as a highly plastic and dynamic 
cellular system ensuring injury detection, robust inflammatory responses and 
resolution. Monocytes entail two main subpopulations currently defined as 
CD14+CD16- and CD14dim CD16+ cells in humans, and Ly6C+ and Ly6C- cells in mice 
(Geissmann et al., 2003; Passlick et al., 1989). Ly6C+ monocytes are inflammatory 
cells with tissue infiltrating capacity, while Ly6C- cells seem to remain in the 
circulation and control vessel wall integrity (Auffray et al., 2007; Geissmann et al., 
2003).  
 Ly6C+ monocytes give rise to Ly6C- monocytes. ‘Converted’ Ly6C+ monocytes 
could represent a minor fraction of Ly6C- monocytes, but single cell RNA-Seq 
profiling did not reveal heterogeneity within Ly6C+ and especially Ly6C- monocyte 
populations under steady state conditions. We can however not absolutely exclude 
that heterogeneity exists, or might arise following challenges, such as reported after 
IFN-J injection (Askenase et al., 2015), as we sequenced only a small fraction 
(~0.5%) of all circulating monocytes.  
Single cell analysis highlighted heterogeneity in the Ly6Cint compartment by revealing 
a transient up-regulation of MHCII genes especially in these cells, which was also 
evident in the ATAC and iChIP analysis. Recently, a MHCII+ cell population within the 
Ly6C+ monocyte compartment was identified and proposed to give preferential rise to 
monocyte-derived DC (Menezes et al., 2016). Like our MHCII-expressing Ly6Cint 
monocytes, these cells expressed the C-type lectin receptor CD209 (DC-SIGN). 
Transferred monocytes did not show any expression of Cd209a or MHCII-related 
genes after 48h, which could imply a direct conversion from Ly6C+ towards Ly6C- 
monocytes without a Cd209a+ intermediate stage. Notably, Cd209a+ monocytes were 
also present in C/EBPE-deficient mice and these cells could hence arise in the BM 
(Menezes et al., 2016). Our fate mapping approach suggests that Ly6Cint Cd209a-
expressing cells are short-lived and likely descendants of BM Ly6C+ monocytes. Also 
human CD14+CD16+ double positive monocytes are characterized by higher MHCII 
expression (Gren et al., 2015; Schmidl et al., 2014; Zawada et al., 2011) and some 
human CD14+CD16+ monocytes may possibly represent equivalents of murine 
MHCII+ Ly6Cint monocytes. 
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  Mechanistically, our findings suggest that C/EBPβ binds to promoter 
and enhancer regions of Nr4a1 in monocyte-derived cells and activates Nr4a1 
expression. Nr4a1 has been previously shown to be obligatory for Ly6C- monocyte 
development (Hanna et al., 2011) Moreover, the same group showed recently that 
the second Nr4a1 enhancer (E2) was crucial for Ly6C- monocyte development in a 
Klf2-dependent manner (Thomas et al., 2017). The authors subsequently focused on 
the control of Nr4a1 expression by the E2 fragment and reported that it was 
independent of C/EBPβ, but under Klf2 control. We confirm these results, but show in 
addition that C/EBPβ binds to both enhancers (E1, E2) and thereby regulates 
expression of Nr4a1. The exact hierarchy of C/EBPβ and Nr4a1 induction remains 
unclear. We noted Cebpbexpression in BM Ly6C+ monocytes prior to Nr4a1 
induction, which appeared in blood Ly6C+ and increased in Ly6C- monocytes. 
Furthermore, Nr4a1 expression was reduced in Ly6C+ and Ly6Cint monocytes 
isolated from C/EBPβ-deficient mice, indicating an upstream role of C/EBPβ. 
Likewise, Hanna et al. revealed a strong reduction of C/EBPβexpression in the 
remaining Ly6C- monocyte population isolated from Nr4a1-deficient mice (Hanna et 
al., 2011). Therefore it seems possible that both transcription factors are connected 
by a regulatory circuit. This is also supported by the fact that a small fraction of BM 
Ly6C- monocytes is still present in C/EBPβ-deficient mice – a observation similar to 
Nr4a1-/- animals (Carlin et al., 2013). 
 The phenotype of Nr4a1-deficient mice was attributed to a decreased survival 
of monocytes, accompanied by increased apoptosis in this cell lineage (Hanna et al., 
2011). Similarly, Cebpb-/- monocytes show increased apoptosis (Tamura et al., 2015). 
However, C/EBPβ-deficient Ly6Cint monocytes lacked the Ly6C- monocyte gene 
signature, which was observed in C/EBPβ-proficient Ly6Cint cells, indicating a 
C/EBPβ function beyond a mere survival phenotype.  
 Collectively, our data indicate that Ly6C+ monocytes represent an unstable cell 
population with a molecular and epigenetic default differentiation potential towards 
Ly6C- monocytes. However, even though Ly6C+ cells seem to represent an a priori 
developmental stage, they are equipped with unique functional properties such as 
tissue infiltration and pro-inflammatory activity (Mildner et al., 2013), which cannot be 
acquired by Ly6C- monocytes (Varol et al., 2009). This raises the questions, whether 
the epigenetic landscape can change under inflammatory conditions to prevent the 
default differentiation into Ly6C- cells. It is possible that the observed shift in human 
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monocyte composition under pathological conditions towards increased abundance 
of CD14+CD16+ cells (reviewed in (Wong et al., 2012)) represents such a case. It will 
be critical to identify how plasticity is preserved in Ly6C+ cells and how Ly6C+ 
monocytes balance their developmental fate to either become circulating Ly6C- 
monocytes or to differentiate into monocyte-derived tissue macrophages.   
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CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to 
and will be fulfilled by the Lead Contact, Steffen Jung (s.jung@weizmann.ac.il). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
The following mouse strains have been used within this study: B6.Cg.129P2-C/EBPb 
tm1Pfj (C/EBPβ-/- (Sterneck et al., 1997)), B6.Cg.129P2-C/EBPtm3.2Acle (coki; 
(Wethmar et al., 2010)), B6.Cg.129P2-C/EBPtm1.2Acle (LIP; (Bégay et al., 2015)) 
and B6.Cg.129P2 (wt, littermate controls). These mice were kept on a mixed 
background. Female animals in an age between 6-12 weeks were used for analysis 
(related to Fig. 5 and Fig. S2). Female C57BL/6J (8 weeks) and CX3CR1Cre mice 
(Yona et al., 2012) crossed to Rosa-YFP mice (Srinivas et al., 2001; 16 weeks) were 
used for single cell sorting (related to Fig. 3 and Fig. S5). Female C57BL/6J (6-8 
weeks) were used for bulk RNA-Seq (related to Fig. 1) and ChIP-Seq as well as 
ATAC-Seq (related to Fig. 4). For cell transfer experiments, BM monocytes from 8 
weeks old female congenic B6.SJL-PtprcaPep3b/BoyJ (CD45.1) were injected into 8 
weeks old female C57BL/6J mice (Harlan). For mixed BM chimeras, 8 weeks old 
female recipient animals (CD45.1/1) were lethally irradiated (950 rad) and 
reconstituted with female donor BM by i.v. injection of 106 BM cells isolated from 
C/EBPβ-/- (CD45.2/2), LIP (CD45.2/2) mice and mixed in a 1:1 ratio with littermate 
(CD45.1/2) BM cells. Mice were kept under Ciproxin (Bayer) antibiotics for 10 
consecutive days and BM chimeras were analyzed 8 weeks after transfer. All mice 
were bred and maintained in specific pathogen-free (SPF) animal facilities at the 
MDC or the Weizmann Institute of Science. Animals were healthy and they were 
healthy and they were not involved in previous procedures. Experiments were 
approved by an Institutional Animal Care Committee (IACUC) in accordance to 
international guidelines. 
 
METHOD DETAILS 
Flow cytometry and cell sorting 
Antibodies against CD11b (M1/70), CD11c (HL3), CD115 (AFS98), CD117 (2B8), Ly-
6C (HK1.4), CD135 (A2F10), Ly6G (1A8), CD19 (6D5), CD3e (145-2c11), CD45.1 
(A20), CD45.2 (1D4), B220 (RA3-6B2), CD62L (MEL-14), MHCII (IAb; AF6-102.1), 
TCRγδ (GL-3), Ter119, NK1.1 (PK136) from Biolegend or eBioscience were used. 
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For sequencing, monocytes were isolated by CD115 biotin antibodies followed by 
anti-biotin MACS without RBC lysis. Monocytes were identified as lineage negative 
(Ter119, B220, CD19, CD3, NK1.1, Ly6G, TCRγδ), CD11b+ and CD115+. Samples 
were flow sorted either using AriaII, AriaIII or Aria-Fusion (BD Biosciences, BD Diva 
Software) cell sorter. Analysis was performed on Fortessa or LSRII (BD Biosciences, 
BD Diva Software) and analyzed with FlowJo software (Treestar). 
 
Bulk RNA sequencing 
RNA-Seq of populations was performed as described previously (Lavin et al., 2014). 
In brief, 103–105 cells from each population were sorted into 50μl of lysis/binding 
buffer (Life Technologies) and stored at -80°C. mRNA was captured with Dynabeads 
oligo(dT) (Life Technologies) according to manufacturer’s guidelines. We used a 
derivation of MARS-seq (Jaitin et al., 2014). Briefly, RNA was reversed transcripted 
with MARS-Seq barcoded RT primer in a 10μl volume with the Affinity Script kit 
(Agilent). Reverse transcription was analyzed by qRT-PCR and samples with a 
similar CT were pooled (up to 8 samples per pool). Each pool was treated with 
Exonuclease I (NEB) for 30min 37°C and subsequently cleaned by 1.2X SPRI beads. 
Afterwards, the cDNA was converted to double-stranded DNA with a second strand 
synthesis kit (NEB) in a 20μl reaction, incubating for 2.5 h at 16 ̊C. The product was 
purified with 1.4x volumes of SPRI beads, eluted in 8μl and in-vitro transcribed (with 
the beads) at 37°C overnight for linear amplification using the T7 High Yield RNA 
polymerase IVT kit (NEB). Following IVT, the DNA template was removed with Turbo 
DNase I (Ambion) 15 min at 37°C and the amplified RNA (aRNA) purified with 1.2x 
volumes of SPRI beads. The aRNA was fragmented by incubating 2.5min at 70°C in 
Zn2+ RNA fragmentation solution (Ambion) and purified with 2X SPRI beads. The 
aRNA (5μl) was preincubated 3 min at 70°C with 1μl of 100μM MARS seq ligation 
adapter; then, 14μl of a mix containing 9.5% DMSO, 1mM ATP, 20% PEG8000 and 1 
U/μl T4 ligase (NEB) in 50 mM Tris HCl pH7.5, 10 mM MgCl2 and 1mM DTT was 
added. The reaction was incubated at 22°C for 2 h. After 1.5X SPRI cleanup, the 
ligated product was reverse transcribed using Affinity Script RT enzyme (Agilent; 
reaction mix contains Affinity Script RT buffer, 10 mM DTT, 4 mM dNTP, 2.5 U/μl RT 
enzyme) and a primer complementary to the ligated adapter. The reaction was 
incubated for 2min at 42°C, 45 min at 50°C and 5 min at 85°C. The cDNA was 
purified with 1.5X volumes of SPRI beads. The library was completed and amplified 
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through a nested PCR reaction with 0.5 μM of P5_Rd1 and P7_Rd2 primers and 
PCR ready mix (Kapa Biosystems). The amplified pooled library was purified with 
0.7X volumes of SPRI beads to remove primer leftovers. Library concentration was 
measured with a Qubit fluorometer (Life Technologies) and mean molecule size was 
determined with a 2200 TapeStation instrument. RNA-Seq libraries were sequenced 
using Illumina NextSeq-500. Raw reads were mapped to the genome (NCBI37/mm9) 
using hisat (version 0.1.6). Only reads with unique mapping were considered for 
further analysis. Gene expression levels were calculated using the HOMER software 
package (analyzeRepeats.pl rna mm9 -d <tagDir> -count exons -condenseGenes -
strand + -raw) (Heinz et al., 2010). Normalization and differential expression analysis 
was done using the DESeq2 R-package. Differential expressed genes were selected 
using a 2-fold change cutoff between at least two populations and adjusted pValue 
for multiple gene testing > 0.05. Gene expression matrix was clustered using k-
means algorithm (matlab function kmeans) with correlation as the distance metric. 
The value of k was chosen by assessing the average silhouette (matlab function 
silhouette) (3) for a range of possible values (4-15). 
 
Indexing-first chromatin IP (iChIP) sequencing 
105 crosslinked cells were used for iChIP-seq, as described (Lara-Astiaso et al., 
2014). Briefly, following crosslinking for 8 min in 1% formaldehyde and quenched for 
5min in 0.125 M glycine, cells were FACS sorted, diluted in harvesting buffer (12mM 
Tris-HCl, 0.1X PBS, 6mM EDTA, 1.2X Protease Inhibitor (Roche)), pelleted by two 
rounds of centrifugation (15min, 3000g, low acceleration and brake) and frozen at -
80°C. Cell aliquots (around 10μl) are thawed on ice and 2μl of 3% SDS is added to 
achieve a concentration of 0.5% SDS. Chromatin was fragmented by sonication at 
high intensity and cycles of 30” ON/30” OFF with the NGS Bioruptor Sonicator 
(Diagenode) for 40min. Cells were diluted 1:5 with sonication equilibration buffer 
(10mM Tris-HCl, 140mM NaCl, 0.1% sodium deoxycholate, 1% Tx-100, 1mM EDTA, 
1X Protease Inhibitor) and sheared chromatin was immobilized on 15μl Dynabeads 
Protein G (ThermoFisher) with 1.3μg of anti-H3 antibody (ab1791, Abcam) for 20h on 
4°C. The H3-bound beads were magnetized and washed 3 times with 150μl 10mM 
Tris-HCl, 1X Protease Inhibitors and resuspended in 20μl of the same buffer. 
Chromatin End Repair was performed by adding 30μl of a master mix: 25μl 2X ER 
mix (50mM Tris-HCl ph 7.5, 20mM MgCl2, 20mM DTT, 2mM ATP, 1mM dNTPs), 2μl 
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T4 PNK enzyme (10 U/μl NEB), and 2μl T4 polymerase (3 U/μl NEB) to each sample 
and incubated at 12°C for 25min, 25°C for 25min, and finally cooled to 4°C. After end 
repair, bead bound chromatin was washed once with 150μl of 10mM Tris-HCl + 
Protease Inhibitors and re-suspended in 40μl of the same buffer. Chromatin was A-
tailed by adding 20μl master mix (17μl A-base add mix, 3μl Klenow (3’->5’ 
exonuclease, 3 U/μl, NEB) to each well and incubated at 37°C for 30 min. Afterwards, 
bead bound chromatin was washed once with 150μl of 10mM Tris-HCl + Protease 
Inhibitors and resuspended in 19μl of the same buffer. Chromatin was indexed by 
adding 5μl of 0.75μM Y- shapped Indexed Adaptors (containing P5 and P7 
sequences) to each well which were ligated to the chromatin's DNA ends by adding 
34μl of AL master mix (29μl 2x Quick Ligation Buffer and 5 μl Quick DNA ligase 
(NEB)) to each well. Samples were mixed and incubated at 25°C for 40min in a 
thermal cycler. Bead bound indexed chromatin was washed once as described 
above in order to remove non-ligated adaptors. After wash, samples were removed 
from the magnet, beads were re-suspended in 12.5μl of 100mM DTT and incubated 
for 5min at room temperature. Then, 12.5μl of 2X Chromatin Release Buffer (500mM 
NaCl, 2% SDS, 2% Sodium Deoxycholate, 2X protease Inhibitors) was added, 
samples were mixed and incubated at 37°C for 30min. After the release incubation, 
magnetic beads were again thoroughly re-suspended and pooled together in groups 
of <10 samples resulting in a pool volume of 200-250μl. The pooled indexed 
chromatin samples were concentrated using a 50Kda cutoff Centricon (Amicon).  
Target antibody was added and incubated at 4°C for 3h, then 50μl with Protein G 
Magentic beads were added and IP was incubated for 1 more hour. For each ChIP, 
we used 1.5μg of anti-H3K4me1 (ab8895; Abcam) and 2.5μg of anti-H3K4me2 
(ab32356; Abcam), anti-H3K4me3 (07-473; Millipore) and anti-H3K27ac (ab4729; 
Abcam). After incubation, ChIP Buffer was removed and samples were washed 5 
times with cold RIPA (200ul per wash), twice with RIPA buffer supplemented with 
500mM NaCl (200ul per wash), twice with LiCl buffer (10mM TE, 250mM LiCl, 0.5% 
NP-40, 0.5% DOC), once with TE (10Mm Tris-HCl pH 8.0, 1mM EDTA), and then 
eluted in 50μl of 0.5% SDS, 300mM NaCl, 5mM EDTA, 10mM Tris-HCl pH 8.0. The 
eluate was treated sequentially with 2μl of RNaseA (Roche, 11119915001) for 30 min 
at 37°C, 2.5μl of Proteinase K (NEB, P8102) for additional two hours at 37°C and 8 
hours at 65°C to revert formaldehyde crosslinking. DNA was purified with SPRI 
beads (90μl, Agencourt AMPure XP beads, Beckman Coulter) according to 
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manufacture’s protocol. The DNA was eluted in 23μl EB buffer (10mM Tris-HCl, pH 
8.0) by pipette mixing 25 times. The library was completed and amplified through a 
PCR reaction with 0.5μM of PCR forward and PCR reverse primers and PCR ready 
mix (Kapa Biosystems). Following the amplification step, DNA concentration was 
measured, and equivalent amounts of barcoded ChIPed DNA from each sample 
were pooled together. After barcoding, pooled DNA was sequenced (HiSeq 1500, 
Illumina) to achieve a minimum of 107 aligned reads per sample. 
 
ATAC sequencing 
20,000 cells were used for ATACseq (Buenrostro et al., 2013) applying described 
changes (Lara-Astiaso et al., 2014). Briefly, nuclei were obtained by lysing the cells 
with cold lysis buffer (10mM Tris-HCl pH 7.4, 10mM MgCl2, 0.1% Igepal CA-630) and 
nuclei were pelleted by centrifugation for 30min at 500g, 4°C using a swing rotor with 
low acceleration and brake settings. Supernatant was discarded and nuclei were re-
suspended in 25μl reaction buffer containing 2μl of Tn5 transposase and 12.5μl of 
TD buffer (Nextera Sample preparation kit from Illumina). The reaction was incubated 
at 37°C for one hour. DNA was released from chromatin by adding 5μl of clean up 
buffer (900mM NaCl, 300mM EDTA), 2μl of 5% SDS and 2μl of Proteinase K (NEB) 
followed by a incubation for 30min at 40ºC. Tagmentated DNA was isolated using 2x 
SPRI beads and eluted in 21μl. For library amplification, two sequential 9-cycle PCR 
were performed in order to enrich small tagmentated DNA fragments. We used 2μl of 
indexing primers included in the Nextera Index kit and KAPA HiFi HotStart ready mix. 
After the first PCR, the libraries were selected for small fragments (less than 600 bp; 
0.65X) using SPRI cleanup. Then a second PCR was performed with the same 
conditions in order to obtain the final library. DNA concentration was measured with a 
Qubit fluorometer (Life Technologies) and library sizes were determined using 
TapeStation (Agilent Technologies). Libraries where sequenced on a Hiseq 1500 for 
an average of 20 million reads per sample 
 
Processing of ChIP-Seq and ATAC-Seq 
Reads were aligned to the mouse reference genome (mm9, NCBI 37) using Bowtie2 
aligner version 2.2.5 (Langmead et al., 2009) with default parameters. The Picard 
tool MarkDuplicates from the Broad Institute (http://broadinstitute.github.io/picard/) 
was used to remove PCR duplicates. To identify regions of enrichment (peaks) from 
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ChIP-seq (H3K4me1, H3K4me2, H3K4me3 and H3K27ac), we used the HOMER 
package makeTagDirectory followed by findPeaks command “-style histone”. For 
ATACseq we used makeTagDirectory followed by findPeaks command “-style factor -
size 300”, respectively (Heinz et al., 2010). Union peaks file were generated for each 
of H3K4me1, H3K4me2, H3K4me3 and H3K27ac by combining and merging 
overlapping peaks in all samples. 
 
Chromatin and Motif Analysis 
All ChIP-seq peaks were binned to 1kb size. To create the table of samples, we used 
annotatePeaks.pl from HOMER package passing the binned peak file and option “-
raw” and normalized to an equal number of reads in merged peaks. We consider 
promoters to be peak center < 1kb from TSS of nearest gene. H3K4me3 regions 
used are only near promotor areas, while binned the peaks of H3K4me1, H3K4me2 
and H3K27ac used are all non-promotor areas. Noise was set at ~80% of all 
normalized value. The region intensity was given in log-base2 of the normalized 
density (log2(x+1)). Fold change bins were considered changing when delta between 
samples (log2(x+noise)) was > 1 (red line in Fig. 4A). Kmeans clustering was 
performed using MATLAB function kmeans with the distance metric set to 
‘‘correlation”. Motif Analysis was performed inside ATAC peaks and differential 
regions were used as input for the HOMER package motif finder algorithm 
findMotifGenome.pl (Heinz et al., 2010). 
 
Single cell sequencing 
MARS-seq reads were processed as previously described (Paul et al., 2015). Briefly, 
mRNA from cells sorted into MARS-seq capture plates was barcoded and converted 
into cDNA and pooled using an automated pipeline. The pooled sample was then 
linearly amplified by T7 in-vitro transcription and the resulting RNA was fragmented 
and converted into a sequencing-ready library by tagging the samples with pool 
barcodes and Illumina adapter sequences during ligation, followed by reverse 
transcription and PCR. Each pool of cells was tested for library quality and 
concentration as described earlier (Jaitin et al., 2014). All RNA-Seq libraries (pooled 
at equimolar concentration) were sequenced using an Illumina NextSeq 500. 
Mapping of reads was done using hisat (version 0.1.6) to mm9 genome. Reads with 
multiple mapping positions were excluded. Reads were associated with genes, if they 
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were mapped to an exon defined by a reference set obtained from Gencode. Exons 
of different genes that share genomic position on the same strand were considered 
as a single gene with concatenated gene symbol. Cells with less than 200 UMIs were 
discarded from the analysis. Genes with mean expression smaller than 0.005 UMIs/ 
cell or with above average expression and low coefficient of variance (< 1.2) were 
also discarded. In order to assess the heterogeneity of blood monocyte subtypes, we 
used a recently published multinomial mixture-model algorithm (Paul et al., 2015) 
(http://compgenomics.weizmann.ac.il/tanay/?page_id=649). A brief summary of the 
algorithm is described below and its detailed description can be found in our earlier 
publication (Paul et al., 2015). Low-level processing of MARS-Seq reads results in a 
matrix U with n rows and m columns, where rows represent genes and columns 
represent cells. Entry Uij contains the number of unique molecular identifiers (UMIs) 
from gene i that were found in cell j. The model assumes that each cell belongs to 
one of K cell types, and that each cell type defines a different distribution of 
transcripts within cells. 
Our model assumes that cells are sampled uniformly from the population, and that 
each cell type dictates a multinomial distribution over the sample of sequenced RNA 
molecules. The model consists of three types of parameters: 
𝑚𝑚𝑚𝑚   - The assignment of cell j to one of K cell types. 
𝑚𝑚,𝑚𝑚𝑚𝑚   -  the probability of observing gene i in cell j, assuming that j belongs to cell    
             type 𝑚𝑚𝑚𝑚. 
𝑚𝑚𝑚𝑚     -  a positive inflation factor accounting for batch effect on the expression of  
             gene i (bj is the batch of cell j).  
A pseudo EM algorithm was used to infer the assignment of cells to types, gene 
probability within cell type, and magnitude of batch effect. The algorithm outline is as 
follows: 
1. Initialize the model: 
a. Estimate β (batch effect vector) from the gene expression in each batch. 
b. Sample a first seed for the cell types at random by drawing uniformly from the list 
of cells. 
2. Repeat a-d to generate the desired number of clusters: 
a. Initialize a pre-seed model using the regularized transcripts of the seed cell. 
b. Find the set of D cells with the highest likelihood to the pre-seed model. Using 
these cells, initialize a new set of parameters α and optimize the likelihood of the 
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selected cells given these parameters and given constant batch parameters. 
Optimization is done using non-linear optimization procedure (L-BFGS-B). Add the 
optimized parameters as a new component to the model. 
c. Compute the log-likelihood of each cell to each of the current initialized types. 
Assign each cell to its corresponding maximum-likelihood cell type. 
d. Sample a new seed cell at random by drawing from quantiles 0-0.05 of the 
maximum likelihoods obtained in c.  
3. Given the current set of multinomial models, calculate the assignment for each cell 
(𝑚𝑚𝑚𝑚) by calculating the maximum assignment probability.  
4. Given the current β and map parameters, use L-BFGS-B to find α (for each cell 
type) that maximizes the likelihood of the U matrix.  
5. Given the current α and the map parameters, use L-BFGS-B to find β that 
maximizes the likelihood of the U matrix. 
6. Return to step 2 and repeat until the likelihood function converges, or the 
maximum number of iterations is reached.  
Since samples derive from different sorting schemes, clustering was performed with 
fixed E values. Dimensionality reduction was performed on log2-transformed 
normalized UMI matrix containing the 477 variable genes by using the diffusion map 
method  (destiny package (Haghverdi et al., 2015)). Projection of genes on the 2D 
map shows normalized values, smoothed by proximity in 2D Euclidean space. 
 
Luciferase reporter assay 
2x105 C/EBPβ-/- MEF cells were seeded in triplicates in 12-well plates 12h prior 
transfection, 500ng Nr4a1 Firefly-luciferase reporter construct (in pGL4.10; Promega), 
100ng C/EBPβ in a pcDNA3.1 background or empty pcDNA3.1 (Addgene) were co-
transfected together with 10ng of a Renilla-luciferase pGL4.70 vector (Promega) 
using PEI. Luciferase expression was assed after 48h using a Berthold Luminometer 
(Centro LB 960). Firefly-luciferase expression was normalized to Renilla-luciferase 
activity to control for transfection efficiency. The data are representative of four 
independent experiments, results from one experiment are plotted as the mean ± 
SEM.  
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
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In all experiments, data are presented as mean ± STD if not stated otherwise. 
Statistical tests were selected based on appropriate assumptions with respect to data 
distribution and variance characteristics. Student’s t test (two-tailed) was used for the 
statistical analysis of differences between two groups. Statistical analyses were done 
applying Students t-test for the calculation of the P-value. Statistical significance was 
defined as P<0.05. Sample sizes were chosen according to standard guidelines. 
Number of animals is indicate as 'n'. Of note, sizes of the tested animal groups were 
also dictated by availability of the transgenic strains and litter sizes, allowing 
littermate controls. Pre-established exclusion criteria are based on IACUC guidelines. 
As for in vitro experiments, samples were excluded from analysis only in case of 
clear technical problems. Animals of the same age, sex and genetic background 
were randomly assigned to treatment groups. The investigator was not blinded to the 
mouse group allocation. Tested samples were blindly assayed. 
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FIGURE LEGENDS  
 
Figure 1. Monocyte development is accompanied by transcriptome changes. 
(A) Schematic of monocyte differentiation.  
(B) Exemplary flow cytometry analysis of murine monocyte identification. 
(C) Expression analysis of murine MDP, cMoP, BM Ly6C+ as well as BM Ly6C- 
monocytes and the three circulating blood monocyte subsets Ly6C+, Ly6Cint and 
Ly6C- by RNA-Seq. Analysis was restricted to genes, which showed a 2-fold 
difference in at least one cell population and sample. K-means clustering was set 
to n = 6. See also related Fig. S1 for GO-enrichment and TF expression in 
monocyte subsets. 3-4 mice were used for this experiment. Similar results of an 
independent experiment can be found in Fig. S2. 
(D) Examples of gene expression from the six identified clusters depicted in C. 
Shown are the mean sequence reads ± STD. 
 
Figure 2. Transferred BM Ly6C+ monocytes develop on the molecular level into 
Ly6C- monocytes. 
(A) Schematic view of monocyte transfer experiment. CD45.1+ Ly6C+ BM monocytes 
were purified by flow cytometry sorting and 2x105 cells were injected into CD45.2 
congenic mice. 24h, 36h and 48h hours after injection, the transferred CD45.1+ 
CD11b+ CD115+ monocytes were re-isolated from the blood by flow cytometry 
sorting and analyzed by RNA-Seq. Ly6C+, Ly6Cint and Ly6C- monocytes from the 
host mice were analyzed by RNA-Seq in parallel and served as control. Similar 
results were obtained for the spleen (Fig. S3). 
(B) Histogram (left panel) and mean fluorescence intensity (MFI; right panel) of Ly6C 
expression on transferred monocytes 24h (red), 36h (grey) and 48h (blue) hours 
after injection. Note that Ly6C protein abundance dropped rapidly between 24h 
and 48h. Two recipients per time point were analyzed and the mean MFI ± STD 
are shown.  
(C) Expression analysis of transferred monocytes before, 24h, 36h and 48h after 
injection as well as host Ly6C+, Ly6Cint and Ly6C- monocyte subsets by RNA-
Seq. Samples were analyzed in duplicates and analysis was restricted to genes, 
which showed a 2-fold difference in at least one cell population and sample. K-
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means clustering was set to n = 8. Respective GO-enrichment can be found in 
Fig. S4A. 
(D) Examples of expression levels from individual genes identified by the cluster 
analysis depicted in C. Shown are the mean sequence reads ± STD.  
(E) Correlation analysis of the expression signature of monocytes isolated 48h after 
transfer against host Ly6C+, Ly6Cint and Ly6C- monocyte subsets. The 1472 
differential expressed genes without the BM-specific cluster I shown in C were 
included (cluster II-VIII) and the average of the duplicates were used for 
calculation. Sequence reads are presented as log2 values. See also related Fig. 
S4B. 
 
Figure 3. Single cells sequencing of murine blood monocytes 
(A) Top: Clustering of 1463 monocytes according to their gene expression profile. 
Four main clusters could be identified. Shown are on the X-axis cells and on the 
Y-axis genes. Shown are 359 differential expressed genes with >100 UMI count. 
See Fig. S5A-F for more details. 
(B) MFI of Ly6C and CD62L expression based on indexed FACS analysis for the 
1098 sequenced monocytes excluding the specifically sorted Ly6Cint cells (365 
cells). 
(C) Marker gene expression in each cluster.  
(D) Diffusion map 2D projection of all sequenced single cells, coloured by their 
assignment to the four monocyte clusters identified in Fig. 3A.  
(E) Black and white depiction of the localisation of the four clusters in the 
dimensionality reduction map. 
(F) Overlay of individual gene expression on the reduction map. 
(G) An additional set of 666 single cell monocytes were sequenced from 
Cx3cr1Cre:R26-YFP mice and assigned to the four clusters by their maximum 
likelihood. Through indexed flow cytometry sorting, each single cell could be 
related to their YFP expression, thereby identifying cluster II and cluster III cells 
as short-lived (BM) Ly6C+ monocyte-descendants. See also Fig. S5G-H for 
detailed analysis. 
 
Figure 4. The epigenetic landscape of murine monocytes. 
(A) Summary of histone modifications (H3K4me1, H3K4me2, H3K4me3 and 
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H3K27ac) in blood Ly6C+ and Ly6C- monocytes. Data were acquired as 
duplicates for all monocyte populations (Fig. S6A) and the signal for each 
population was merged for comparative analysis. Data are represented as log2. 
(B) Summary of expression (RNA), methylation (H3K4me1, H3K4me2, H3K4me3 
and H3K27ac) and open chromatin (ATAC) changes in Ly6C+ and Ly6C- 
monocytes. Shown are the percentages of 2-fold changing gene peaks 
compared to all detected gene peaks. 
(C) Examples of H3K4me2 (the first three rows), H3K4me3 (middle rows) and 
H3K27ac (lower three rows) in Ly6C+ (dark red), Ly6Cint (red) and Ly6C- 
monocytes (orange). Corresponding H3K4me1 signal can be found in Fig. S6B. 
Blue areas indicate changing promoters and green areas changing enhancers. 
(D) Heatmap of differential modified gene loci with at least 2-fold change in Ly6C+, 
Ly6Cint or Ly6C- monocytes, respectively. Note the intermediate phenotype of 
Ly6Cint monocytes in sharing histone marks with either Ly6C+ or Ly6C- 
monocytes. 
(E) Analysis of all 40,572 detected ATAC peaks, from which 423 peaks showed an at 
least 50% higher read count in Ly6C+ monocytes (dark red) and 886 peaks were 
enriched in Ly6C- monocytes (orange). Examples of IGV tracks can be found in 
Fig. S6C. 
(F) Homer motif enrichment for TF binding sites in genes that are either more open in 
Ly6C+ monocytes (423 genes; upper graph) or in Ly6C- monocytes (886 genes; 
lower graph). Shown are the p-values (in log10) and the corresponding motifs. 
(G) Gene expression of TF in Ly6C+, Ly6Cint and Ly6C- monocytes that were 
identified by the motif enrichment in F. Shown are the mean sequence reads ± 
STD. More related genes can be found in Fig. S6D.  
 
Figure 5. Ly6C- monocyte development depends on the expression of C/EBPE 
(A) Flow cytometry analysis of blood monocytes isolated from C/EBPE-deficient mice 
and littermate controls. Monocytes were identified as CD11b+ and CD115+ and 
separated according to Ly6C and CD11c expression. Two independent 
experiments were pooled. N = 6-8 mice. Each symbol represents one animal. 
Asterisk indicates statistical difference with p < 0.05 according to student’s t-test.  
(B) Frequency of BM monocyte populations and their precursors out of Linneg CD115+ 
cells isolated from C/EBPE-deficient mice and littermate controls. 4 animals per 
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group were used and each symbol represents one animal. Asterisk indicates 
statistical difference with p < 0.05 according to student’s t-test.  
(C) Mixed bone marrow chimera experiment in which C/EBPE-deficient CD45.2 BM 
cells were mixed with CD45.1-2 littermate BM cells and injected into lethally 
irradiated CD45.1 recipients. Analysis of the indicated cell populations was 
performed 8 weeks after transfer and shown is the log10 ratio of CD45.1-2+ cells 
to CD45.2+ cells. 4 animals were used in this experiment and each symbol 
represents one recipient. The experiment was performed twice with similar 
results.  
(D) Analysis of transgenic mice, which express in the wt C/EBPE locus either the 
short, N-terminally truncated C/EBPE version LIP or the wt full-length C/EBPE 
construct (coki). Monocytes were identified as CD11b+ CD115+ and separated 
according to Ly6C and CD11c expression. 4-6 animals were analyzed and each 
symbol represents one animal. Asterisk indicates statistical difference with p < 
0.05 according to Student’s t-test. 
(E) Gene expression analysis by RNA-Seq of C/EBPE-deficient and littermate 
monocytes. Since Ly6C- monocyte were strongly reduced in C/EBPE-/- mice, only 
Ly6C+ and Ly6Cint monocytes were analyzed from this genotype. Samples were 
analyzed in duplicates and analysis was restricted to genes, which showed a >2-
fold difference in at least one cell population and sample. K-means clustering 
was set to n = 6.  
(F) Examples of gene expression in wt and C/EBPE-deficient monocytes. Shown are 
the mean sequence reads ± STD. Note the strong up-regulation of MHCII-related 
genes in C/EBPE-deficient Ly6Cint monocytes. 
 
Figure 6. C/EBPEbinds to Nr4a1 enhancer elements and induces Nr4a1 
expression 
(A) Open chromatin structure of the first Nr4a1 enhancer elements in Ly6C+, Ly6Cint 
and Ly6C- blood monocytes (black IGV tracks) as well as in vitro monocyte-
derived cells (grey IGV track; data was taken from (Bornstein et al., 2014)). ChIP 
analysis of C/EBPE-bound chromatin regions in in vitro monocyte-derived cells 
(red IGV track; data was taken from (Bornstein et al., 2014)) shows the binding of 
C/EBPE to three enhancer elements with different C/EBPE motives. 
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(B) Activity reporter assay of different Nr4a1 enhancer elements cloned in front of a 
luciferase gene. The constructs were transfected into MEF Cebpb-/- cells, which 
further received by transfection either 100ng control or C/EBPE-containing 
plasmids. Shown is one experiment out of four with similar results. 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Anti-Ly6C FITC (clone HK1.4) Biolegend Cat# 128006 
RRID:AB_1186135 
Anti-Ly6C PerCP-Cy5.5 (clone HK1.4) eBioscience Cat# 45-5932 
RRID:AB_1518763 
Anti-Ly6C APC (clone HK1.4) Biolegend Cat# 128016 
RRID:AB_1732076 
Anti-Ly6C APC-Cy7 (clone HK1.4) Biolegend Cat# 128025 
RRID:AB_10643867 
Anti-CD11c APC (clone N418) Biolegend Cat# 117310 
RRID:AB_313779 
Anti-CD11c PE (clone N418) Biolegend Cat# 117307 
RRID:AB_313776 
Anti-CD115 Biotin (clone AFS98) Biolegend Cat# 135507 
RRID:AB_2028401  
Anti-CD115 PE (clone AFS98) Biolegend Cat# 135507 
RRID:AB_1937253 
Anti-CD115 PE-Cy7 (clone AFS98) Biolegend Cat# 135524 
RRID:AB_2566460 
Anti-CD45.2 Pacific Blue (clone 104) Biolegend Cat# 109820 
RRID:AB_492872 
Anti-CD45.2 FITC (clone 104) Biolegend Cat# 109806 
RRID:AB_313443 
Anti-CD45.1 PE (clone A20) Biolegend Cat# 110707 
RRID:AB_313496 
Anti-CD45.1 APC (clone A20) Biolegend Cat# 110714 
RRID:AB_313503 
Anti-CD3e BV421 (clone 145-2C11) Biolegend Cat# 100335 
RRID:AB_10898314 
Anti-TCRgd BV421 (clone GL3) Biolegend Cat# 118119 
RRID:AB_10896753 
Anti-Ly6G BV421 (clone 1A8) Biolegend Cat# 127627 
RRID:AB_10897944 
Anti-Nk1.1 BV421 (clone PK136) Biolegend Cat# 108732 
RRID:AB_2562218 
Anti-B220 BV421 (clone RA3-6B2) Biolegend Cat# 103240 
RRID:AB_11203896 
Anti-CD19 BV421 (clone 6D5) Biolegend Cat# 115538 
RRID:AB_11203527 
Anti-Ter119 BV421 (clone TER119) Biolegend Cat# 116234 
RRID:AB_2562917 
Anti-CD11b APC (clone M1/70) Biolegend Cat# 101211 
RRID:AB_312794 
Anti-CD11b PerCP-Cy5.5 (clone M1/70) Biolegend Cat# 101228 
RRID:AB_893232 
Anti-CD11b PE-Cy7 (clone M1/70) Biolegend Cat# 101215 
RRID:AB_312798 
Anti-CD135 Biotin (clone A2F10) eBioscience Cat# 13-1351-81 
RRID:AB_466598 
Anti-CD62L PE (clone MEL-14) eBioscience Cat# 12-0621-81 
RRID:AB_465720 
Supplemental STAR methods Click here to download Supplemental Text & Figures Mildner et
al., STAR methods table 2404.docx
 Anti-CD117 PE/Cy7 (clone 2B8) Biolegend Cat# 105813 
RRID:AB_313222 
Anti-I-Ab PE/Cy7 (clone AF6-120.1) Biolegend Cat# 116420 
RRID:AB_10575296 
Anti-I-Ab PerCP-Cy5.5 (clone AF6-120.1) Biolegend Cat# 116416 
RRID:AB_1953309 
Anti-Ly6G APC-Cy7 (clone 1A8) Biolegend Cat# 127623 
RRID:AB_10645331 
Anti-B220 FITC (clone RA3-6B2) Biolegend Cat# 103206 
RRID:AB_312991 
Anti-B220 APC (clone RA3-6B2) Biolegend Cat# 103211 
RRID:AB_312996 
Anti-CD4 APC (clone GK1.5) Biolegend Cat# 100411 
RRID:AB_312696 
Anti-CD8a APC (clone 53-6.7) eBioscience Cat# 17-0081-82 
RRID:AB_469335 
Anti-Ly6G APC (clone 1A8) eBioscience Cat# 17-9668-80 
RRID:AB_2573306 
Anti-Nk1.1 APC (clone PK136) eBioscience Cat# 17-5941-63 
RRID:AB_469477 
Anti-TCRgd APC (clone GL3) Biolegend Cat# 118116 
RRID:AB_1731813 
Anti-biotin MicroBeads Miltenyi Cat# 130-090-485 
RRID:AB_244365 
Anti-H3K27ac antibody Abcam Cat# ab4729 
RRID:AB_2118291 
Anti-Histone H3 (tri methyl K4) antibody Millipore Cat# 07-473 
RRID:AB_1977252 
Anti-Histone H3 (di methyl K4) antibody Abcam Cat# ab32356 
RRID:AB_732924 
Anti-Histone H3 (mono methyl K4) antibody Abcam Cat# ab8895 
RRID:AB_306847 
Anti-Histone H3 Abcam Cat# ab1791 
RRID:AB_302613 
   
Chemicals, Peptides, and Recombinant 
Proteins 
  
Dynabeads® Oligo(dT)25 ThermoFischer Cat# 61005 
Agencourt AMPure XP Beckman Coulter Cat# A63881 
Exonuclease I New England Biolabs Cat# M0293L 
NEBNext® mRNA Second Strand Synthesis 
Module 
New England Biolabs Cat# e6111L 
RNA Fragmentation Reagents ThermoFischer Cat# AM8740 
Turbo DNase I ThermoFischer Cat# AM2239 
T4 RNA Ligase 1 New England Biolabs Cat# M0204L 
HiScribe™ T7 High Yield RNA Synthesis Kit New England Biolabs Cat# E2040 
Kapa hifi PCR Kits Kapabiosystems Cat# KK2602 
AffinityScript Multiple Temperature Reverse 
Transcriptase 
Agilent Cat# 600109 
PowerUp™ SYBR® Green Master Mix ThermoFischer Cat# A25777 
T4 Polynucleotide Kinase New England Biolabs Cat# M0201 
cOmpleteTM Protease Inhibitor Cocktail Sigma-Aldrich Cat# 11697498001 
Dynabeads® Protein G ThermoFisher Cat# 1004D 
 Klenow Fragment (3’Æ 5’ exo-) New England Biolabs Cat# M0212 
Proteinase K New England Biolabs Cat# P8102 
RNaseA Roche Cat# 11119915001 
PE/Cy7 Streptavidin BioLegend Cat# 405206 
BV605 Streptavidin Biolegend Cat# 405229 
Critical Commercial Assays   
Quick LigationTM Kit New England Biolabs Cat# M2200 
Amicon Ultra-15 Merck Cat# UFC905024 
Nextera Sample Preparation Kit Illumina Cat# FC-121-1030 
   
Deposited Data 
RAW and analysed data GEO GSE95702 
   
Experimental Models: Organisms/Strains 
Mouse: Cx3cr1-Cre Laboratory of S. Jung Yona et al., 2013 
Mouse: Cebpb-/- Laboratory of R.C. Smart Sterneck et al., 2006 
Mouse: LIP Laboratory of A. Leutz Bégay et al., 2015 
Mouse: CoKi Laboratory of A. Leutz Wethmar et al., 2010 
Mouse: RosaYFP Laboratory of F. Costantini Srinivas et al., 2001 
Mouse: CD45.2 (WT) Harlan Stock: B6.Cg.129P2 
Mouse: CD45.1 Harlan Stock: B6.SJL-PtprcaPep3b/BoyJ 
   
Oligonucleotides   
ChIP Universal Adaptor 5’ACACTCTTTCCCTACACGAC
GCTCTTCCGATC*T-3′, where 
* indicates phosphothionate 
modification. 
 
ChIP Indexed Adaptor 5'GATCGGAAGAGCACACGTC
TGAACTCCAGTCACXXXXXXA
TCTCGTATGCCGTCTTCTGTT
- 3', where XXXXXX is the 
barcode for sample multiplexing 
 
Y- Shaped Indexed adaptors Anneal ssUniversal Adaptor and 
ssIndexed Adaptors to obtain Y-
shaped Indexed Adaptors. 
 
ChIP PCR for 5'-
AATGATACGGCGACCACCGA
GATCTACACTCTTTCCCTACA
CGAC-3′ 
 
ChIP PCR rec 5’-
CAAGCAGAAGACGGCATACG
AGAT-3′ 
 
MARS-Seq barcoded RT 
primer 
CGATTGAGGCCGGTAATACG
ACTCACTATAGGGGCGACGT
GTGCTCTTCCGATCTXXXXXX
NNNNTTTTTTTTTTTTTTTTTTT
TN, where XXXXXX is the  
 
MARS-Seq ligation primer AGATCGGAAGAGCGTCGTGTAG, modified with a phosphate group at 5' 
and a C3 spacer (blocker) at the 3' 
MARS-Seq 2nd RT primer TCTAGCCTTCTCGCAGCACATC 
 MARS-Seq P5_Rd1  
PCR forward 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC
TCTTCCGATCT  
MARS-Seq P7_Rd2  
PCR reverse 
CAAGCAGAAGACGGCATACGAGATGTGACTGGAGTTCAGACGTGTG
CTCTTCCGATCT 
  
Recombinant DNA 
pcDNA3.1 Addgene  
pGL4.10 Promega Cat# E665A 
pGL4.70 Promega Cat# E6881 
   
Software and Algorithms   
GraphPad Prism 6 GraphPad 
Software, Inc., 
Carlifornia 
 
FlowJo 8.7 TreeStar; 
FlowJo LLC; 
Ashland, 
Oregon 
 
MarkDuplicates http://broadinstit
ute.github.io/pic
ard/ 
 
Bowtie2 aligner version 2.2.5 http://bowtie-
bio.sourceforge.
net/bowtie2/inde
x.shtml 
 
HOMER http://homer.ucs
d.edu/homer/intr
oduction/install.
html 
 
DAVID https://david.ncifcrf.gov/ 
HISAT https://ccb.jhu.edu/software/hisat/index.shtml 
Picard http://broadinstitute.github.io/picard/ 
Other  
multinomial mixture-model 
algorithm 
this study http://compgenomics.weizmann.ac.il/ta
nay/?page_id=649 
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SUPPLEMENTARY Table legends  
 
 
 
Supplementary Table 1. Core gene expression in the identified four clusters by 
single cell RNA-Seq. Supporting text figure 3. 
 
 
 
Supplementary Table 2. Promoter and enhancer changes in Ly6C+, Ly6Cint and 
Ly6C- monocytes. Supporting text figure 4. 
Full list of H3K4me1, H3K4me2, H3K4me3 and H3K27ac changes in the three 
monocyte populations as identified and depicted in the X/Y graphs of Fig. 4A.  
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Supplementary Figure 1. GO-enrichment and TF expression in monocytes and 
their precursors. Supporting main text figure 1. 
(A) P-values of selected GO-enrichment in the six clusters depicted in Fig. 1C. 
Significant changes in GO terms (biological processes) and in KEGG pathways 
are shown. Redundant or overlapping enrichments were not depicted. 
(B) Transcription factor expression in the six clusters depicted in Fig. 1C. TF were 
taken from the riken website (http://genome.gsc.riken.jp/TFdb/tf_list.html) and 
from http://www.tfcat.ca/index.php. 
  
 
Supplemental Text & Figures Click here to download Supplemental Text & Figures Mildner
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Supplementary Figure 2. Independent monocyte profiling by RNA-Seq 
Supporting main text figure 1. 
(A) Expression analysis of an additional set of murine MDP, cMoP, BM Ly6C+ 
monocytes and the three circulating blood monocyte subsets Ly6C+, Ly6Cint and 
Ly6C- by RNA-Seq. Samples were analyzed in duplicates and analysis was 
restricted to genes, which showed a 2-fold difference in at least one cell 
population and sample. K-means clustering was set to n = 8.  
(B) Examples of gene expression from the eight identified clusters depicted in C. 
Shown are the mean sequence reads ± STD. Note that cd209a and MHCII-
related gene expression was in this experiment restricted to Ly6Cint monocytes 
and not expressed by Ly6C- monocytes. 
 Supporting main text figure 1. 
 	
 
 
 
 
 	
 
Supplementary Figure 3. Transferred BM Ly6C+ monocytes develop on the 
molecular level into splenic Ly6C- monocytes. Supporting main text figure 2. 
(A) Schematic view of monocyte transfer experiment. CD45.1+ Ly6C+ BM monocytes 
were purified by FACS sorting and 2x105 cells were injected into CD45.2 
congenic mice. 24h, 36h and 48h hours after injection, the transferred CD45.1+ 
CD11b+ CD115+ monocytes were re-isolated from the spleen by FACS sorting 
and analyzed by RNA-Seq. Splenic Ly6C+, Ly6Cint and Ly6C- monocytes from 
the host mice were analyzed by RNA-Seq in parallel and served as control. 
(B) Histogram (left panel) and mean fluorescence intensity (MFI; right panel) of Ly6C 
expression on transferred splenic monocytes 24h (red), 36h (grey) and 48h 
(blue) hours after injection. Two recipients per time point were analyzed and the 
mean MFI ± STD are shown.  
(C) Expression analysis of transferred monocytes from the spleen before, 24h, 36h 
and 48h after injection as well as host splenic Ly6C+, Ly6Cint and Ly6C- 
monocyte subsets by RNA-Seq. We used the same clustering as shown in Fig. 
2C to indicate overlapping transcriptional regulation in both organs.  
(D) Examples of expression levels from individual genes identified by the cluster 
analysis depicted in C. Shown are the mean sequence reads ± STD. 
(E) Correlation analysis of the expression signature of splenic monocytes isolated 
48h after transfer against host splenic Ly6C+, Ly6Cint and Ly6C- monocyte 
subsets. The 1472 differential expressed genes without the BM-specific genes 
from C (cluster II-VIII) and the average of the duplicates were used for calculation. 
Sequence reads are presented as log2 values. 
 
  
 	
 
 
 
 
Supplementary Figure 4. GO-enrichment in host and transferred blood 
monocytes and conversion pattern of the 24h monocyte graft. 
Supporting main text figure 2. 
(A) P-values of selected GO-enrichment in the eight clusters depicted in Fig. 2C. The 
main GO terms belong to biological processes and cellular component. 
Redundant or overlapping enrichments were not depicted. 
(B) Correlation analysis of the expression signature of monocytes isolated 24h after 
transfer against host Ly6C+, Ly6Cint and Ly6C- monocyte subsets. The 1472 
differential expressed genes without the BM-specific cluster I from Fig. 2C were 
used (cluster II-VIII) and the average of the duplicates were used for calculation. 
Sequence reads are presented as log2 values. 
 
  
 	
 
 
 
  
 	
Supplementary Figure 5. FACS gating strategy of monocytes for single cell 
RNA sequencing. Supporting main text figure 3. 
(A) Monocytes were isolated from the blood of wt mice by CD115-biotin followed by 
anti-biotin MACS enrichment without red blood cell lysis. Cells were defined and 
sorted as lineage negative (B220, CD19, CD3, NK1.1, Ly6G, TCRγδ), CD11b+ 
and CD115+.  
(B) Read and UMI count of the 1463 analyzed single cells.  
(C) Distribution of the four clusters in the 1098 total monocytes (upper panel) and in 
the 365 Ly6Cint cells. 
(D) Detailed gene expression analysis of selected genes in the four clusters. 
(E) Bar diagram of average gene expression in the four clusters. Note that cd209a 
was specifically expressed in cluster II cells. A full list of the detected genes as 
average in each cluster can be found in Suppl. Tabl. 1. 
(F) FACS analysis of blood monocytes for MHCII (IAb) expression. A small subset of 
Ly6Cint monocytes express MHCII on their surface. 
(G) Clustering of 666 monocytes isolated from cx3cr1Cre:r26-YFP mice according to 
their gene expression profile. Three main clusters could be identified in these 
mice with cluster I comprising of 212 cells, cluster II 50 cells and cluster III with 
404 cells. Shown are on the X-axis cells and on the Y-axis genes.  
(H) Marker gene expression in each cell identifies cluster I as Ly6C+ monocytes, 
cluster II as Ly6Cint monocytes and cluster III as the Ly6C- subset. Cluster II 
monocytes were characterized by MHCII gene expression. 
 
  
 	
 
 
  
 	
Supplementary Figure 6. Correlation of sequencing samples. 
Supporting main text figure 4. 
(A) Correlation analysis of the duplicates performed for Ly6C+ and Ly6C- monocytes. 
Shown are the correlations for RNA-Seq, ATAC, H3K4me1, H3k4me3 and 
H3k27ac. Data are presented in log2 values. 
(B) Examples of H3K4me1 signal in Ly6C+ (dark red), Ly6Cint (red) and Ly6C- 
monocytes (orange).  
(C) Examples of open chromatin structures in Ly6C+ (dark red), Ly6Cint (red) and 
Ly6C- monocytes (orange). Shown are IGV tracks spanning 100kb. The location 
of the indicated gene is depicted as a black arrow. Grey boxes indicate changes 
in open chromatin areas.  
(D) TF expression in Ly6C+, Ly6Cint and Ly6C- monocytes, which were further 
predicted by Homer motif enrichment as shown in Fig. 4F. 
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